ViewPoints Article: Organs on a chip (OOCs) – Transforming Animal Testing
Shots: Repare to receive $15M upfront, $160M milestones and royalties on sales of product from ONO. Repare to get exclusive development and commercialization rights for Repare’s Polθ Inhibitor Program in Japan, South Korea, Taiwan, Hong Kong, Macau and ASEAN countries Repare will retain development and commercialization rights (ex- ONO’s territory) for Polθ Inhibitor Program in […]Read More
